What You Should Know:
- M12, Microsoft’s venture fund invests
in Andor Health’s AI-driven virtual health platform.
- The funds will be used for accelerating
sales and marketing by expanding into new markets beyond the U.S. Additionally, the funds will be leveraged for
investing in enhanced R&D engineering.
Andor Health, the company that harnesses machine and human intelligence to change the way care teams connect and collaborate, announced a
Read More
Microsoft Ventures
Livongo Health Acquires Disease Prevention Startup Retrofit
Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better has acquired Retrofit, a provider of innovative weight-management and disease-prevention programs that transform lives, workplaces and communities. The acquisition provides Livongo with a proven, evidence-based, Diabetes Prevention Program, enhances its data science capabilities, and boosts expertise in holistic weight management, including nutrition, exercise and mindset."Retrofit
Read More
Livongo Health Raises $105M for Mobile Diabetes Management, Inks Deal with Cambia Health
Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better has raised $105 million in funding led by existing investors General Catalyst and international investment company Kinnevik. Existing investors DFJ, Kleiner Perkins Caufield & Byers , Merck Global Health Innovation Fund, Microsoft Ventures, Sapphire Ventures, Zaffre Investments, and 7wire Ventures participated in the round along with new investor Echo Health Ventures.Livongo
Read More
Livongo Health Raises $52.5M to Expand Diabetes Management to International Markets
Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better has raised $52.5 million in growth funding co-led by existing investor General Catalyst and international investment company Kinnevik. Singapore-based EDBI, American Investment Holdings LLC, and Microsoft Ventures also joined the round including participation from previous investors. The company plans to utilize the funding to expand its diabetes management to international markets
Read More
